169 related articles for article (PubMed ID: 31274235)
1. Effects of aging, baseline renal function and stage of HIV infection on post-treatment changes in renal function among HIV-infected patients: a retrospective cohort study.
Ding Y; Duan S; Ye R; Yao S; Cao D; Yang Y; Wang J; Shi Y; Zhang Y; Li P; Xu Y; Wei H; Yin C; Liu X; He N
HIV Med; 2019 Oct; 20(9):591-600. PubMed ID: 31274235
[TBL] [Abstract][Full Text] [Related]
2. Chronic kidney disease in Australian Human Immunodeficiency Virus-infected patients: Analysis of the Australian HIV Observational Database.
Cheung J; Puhr R; Petoumenos K; Cooper DA; Woolley I; Gunathilake M; Raymond N; Varma R; O'Connor CC; Gracey DM
Nephrology (Carlton); 2018 Aug; 23(8):778-786. PubMed ID: 28703924
[TBL] [Abstract][Full Text] [Related]
3. Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care.
Ganesan A; Krantz EM; Huppler Hullsiek K; Riddle MS; Weintrob AC; Lalani T; Okulicz JF; Landrum M; Agan B; Whitman TJ; Ross MJ; Crum-Cianflone NF;
HIV Med; 2013 Feb; 14(2):65-76. PubMed ID: 22808988
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.
Kalayjian RC; Lau B; Mechekano RN; Crane HM; Rodriguez B; Salata RA; Krishnasami Z; Willig JH; Martin JN; Moore RD; Eron JJ; Kitahata MM
AIDS; 2012 Sep; 26(15):1907-15. PubMed ID: 22824630
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy.
Calza L; Sachs M; Colangeli V; Borderi M; Granozzi B; Malosso P; Comai G; Corradetti V; La Manna G; Viale P
Clin Exp Nephrol; 2019 Nov; 23(11):1272-1279. PubMed ID: 31327092
[TBL] [Abstract][Full Text] [Related]
6. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.
Mocroft A; Lundgren JD; Ross M; Fux CA; Reiss P; Moranne O; Morlat P; Monforte Ad; Kirk O; Ryom L;
Lancet HIV; 2016 Jan; 3(1):e23-32. PubMed ID: 26762990
[TBL] [Abstract][Full Text] [Related]
7. Renal toxicity of long-term therapy with tenofovir in HIV-infected patients.
Monteagudo-Chu MO; Chang MH; Fung HB; Bräu N
J Pharm Pract; 2012 Oct; 25(5):552-9. PubMed ID: 22551561
[TBL] [Abstract][Full Text] [Related]
8. Changes in renal function with long-term exposure to antiretroviral therapy in HIV-infected adults in Asia.
Joshi K; Boettiger D; Kerr S; Nishijima T; Van Nguyen K; Ly PS; Lee MP; Kumarasamy N; Wong W; Kantipong P; Cuong DD; Kamarulzaman A; Choi JY; Zhang F; Chaiwarith R; Ng OT; Kiertiburanakul S; Sim BLH; Merati TP; Yunihastuti E; Ditangco R; Ross J; Pujari S
Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1209-1216. PubMed ID: 30246898
[TBL] [Abstract][Full Text] [Related]
9. Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa.
Kamkuemah M; Kaplan R; Bekker LG; Little F; Myer L
Trop Med Int Health; 2015 Apr; 20(4):518-26. PubMed ID: 25442109
[TBL] [Abstract][Full Text] [Related]
10. Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting.
Kaboré NF; Poda A; Zoungrana J; Da O; Ciaffi L; Semdé A; Yaméogo I; Sawadogo AB; Delaporte E; Meda N; Limou S; Cournil A
BMC Nephrol; 2019 May; 20(1):155. PubMed ID: 31064340
[TBL] [Abstract][Full Text] [Related]
11. Kidney dysfunction associated with tenofovir exposure in human immunodeficiency virus-1-infected Taiwanese patients.
Huang YS; Chan CK; Tsai MS; Lee KY; Lin SW; Chang SY; Hung CC; Chang SC
J Microbiol Immunol Infect; 2017 Oct; 50(5):595-603. PubMed ID: 26514942
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
Mocroft A; Lundgren JD; Ross M; Law M; Reiss P; Kirk O; Smith C; Wentworth D; Neuhaus J; Fux CA; Moranne O; Morlat P; Johnson MA; Ryom L; ; ; ; ;
PLoS Med; 2015 Mar; 12(3):e1001809. PubMed ID: 25826420
[TBL] [Abstract][Full Text] [Related]
13. Serum albumin and kidney function decline in HIV-infected women.
Lang J; Scherzer R; Tien PC; Parikh CR; Anastos K; Estrella MM; Abraham AG; Sharma A; Cohen MH; Butch AW; Nowicki M; Grunfeld C; Shlipak MG
Am J Kidney Dis; 2014 Oct; 64(4):584-91. PubMed ID: 25059222
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.
Peters L; Grint D; Lundgren JD; Rockstroh JK; Soriano V; Reiss P; Grzeszczuk A; Sambatakou H; Mocroft A; Kirk O;
AIDS; 2012 Sep; 26(15):1917-26. PubMed ID: 22781222
[TBL] [Abstract][Full Text] [Related]
15. Determinants and Incidence of Chronic Kidney Disease with Tenofovir- Based Antiretroviral Therapy Regimens: A Cohort Study in HIV-Infected Adults in South China.
Liu F; Wang Y; Liu H; Chen C; Miao LB; Li ZY; Wang MC; Huang JS; Bao JF
Curr HIV Res; 2022; 20(3):242-250. PubMed ID: 36111752
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study.
Domingo P; Suarez-Lozano I; Gutierrez F; Estrada V; Knobel H; Palacios R; Antela A; Blanco JR; Fulladosa X;
Nefrologia (Engl Ed); 2019; 39(5):497-505. PubMed ID: 31027896
[TBL] [Abstract][Full Text] [Related]
17. Baseline kidney function as predictor of mortality and kidney disease progression in HIV-positive patients.
Ibrahim F; Hamzah L; Jones R; Nitsch D; Sabin C; Post FA;
Am J Kidney Dis; 2012 Oct; 60(4):539-47. PubMed ID: 22521282
[TBL] [Abstract][Full Text] [Related]
18. Renal safety of coformulated tenofovir/emtricitabine vs other nucleoside analogues in combination therapy in antiretroviral-naive patients aged 50 years or older in Spain: The TRIP study.
Pedrol E; Caro-Murillo AM; Castaño MA; Riera M; Olalla J; Domingo P; Arazo P; Gómez-Sirvent JL; Pulido F; Romero-Palacios A; Aguirrebengoa K; Vera F; Ferrer P; Blanco Ramos JR
HIV Clin Trials; 2015; 16(1):43-8. PubMed ID: 25777189
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
Rossi C; Raboud J; Walmsley S; Cooper C; Antoniou T; Burchell AN; Hull M; Chia J; Hogg RS; Moodie EE; Klein MB;
BMC Infect Dis; 2017 Apr; 17(1):246. PubMed ID: 28376824
[TBL] [Abstract][Full Text] [Related]
20. Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.
Kooij KW; Vogt L; Wit FWNM; van der Valk M; van Zoest RA; Goorhuis A; Prins M; Post FA; Reiss P;
J Infect Dis; 2017 Sep; 216(6):622-631. PubMed ID: 28934420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
